top of page
Search

The Concentrated Shareholder’s Dilemma: Wealthy on Paper, Limited in Liquidity

Writer: Altivolus Capital
Altivolus Capital
10m
16 min read
The asset that created the wealth may also be the asset the shareholder is most reluctant—or least able—to sell.

For certain qualified shareholders holding eligible publicly traded securities on international exchanges, securities-backed lending may provide another possibility. Instead of immediately liquidating the position, the shareholder may be able to pledge eligible shares as collateral for a loan.

That does not eliminate risk. It replaces one financial decision—selling—with another—borrowing against a volatile asset. Understanding that distinction is essential.


What Is a Concentrated Shareholding?

A portfolio is concentrated when a substantial portion of its value depends on one company, industry, market or closely related group of assets.

There is no universal percentage at which concentration suddenly begins. A position representing 15% of a diversified institutional portfolio may deserve close attention, while a founder whose company shares constitute 85% of personal net worth faces a dramatically different situation.

Concentrated shareholders commonly include:

  • Founders who retained substantial ownership after an initial public offering

  • Executives compensated partly through company shares

  • Early investors whose holdings appreciated significantly

  • Families holding shares accumulated over several generations

  • Strategic investors with large positions in public companies

  • Business owners who received listed shares through a merger or acquisition

  • Family offices whose wealth remains linked to one successful enterprise

Concentration can be a source of extraordinary wealth. It can also create extraordinary dependence on a single security.

FINRA describes concentration risk as the potential for amplified losses when too much of a portfolio is invested in one security, asset class or market segment. Diversification may reduce the danger of a major loss caused by overexposure to a single investment, although it cannot eliminate market risk altogether. (FINRA: Concentration Risk)

For many major shareholders, however, diversification is easier to recommend than to execute. The shareholder may have strategic, economic, contractual, emotional or tax-related reasons for retaining the position.


Why “Wealthy on Paper” Can Still Mean “Short on Cash”

A brokerage statement may display a large market value, but that figure does not mean the full amount can be converted into cash immediately—or converted without consequences.

1. Selling may reduce control or influence

For founders and strategic shareholders, ownership is not merely a line on a balance sheet. It may carry voting power, board influence, market credibility and a meaningful role in the company’s future.

A major sale could reduce that influence. If the position is associated with control rights, shareholder agreements or governance arrangements, even a modest reduction may matter.

2. A large sale can affect the market

A quoted share price normally reflects the price of relatively small transactions at the margin. It does not guarantee that millions of shares can be sold at the same price.

If a shareholder attempts to sell a position that is large relative to normal daily trading volume, the market may not absorb it efficiently. The seller may experience:

  • Price slippage

  • Wider bid-ask spreads

  • Lower execution prices

  • Extended disposal periods

  • Increased market attention

  • Potential downward pressure on the security

A $100 million position on a screen is not necessarily equivalent to $100 million in immediately realizable cash.

3. The timing may be unattractive

The company may be approaching an important commercial milestone. The sector may be temporarily out of favor. The shareholder may believe the market is undervaluing the business.

Selling today could mean giving up participation in a recovery, expansion or long-term growth story. Of course, the opposite is also possible: the stock could decline further. Retaining shares preserves both the potential upside and the downside exposure.

4. The sale may attract attention

Transactions by founders, directors and other insiders may be subject to applicable disclosure requirements, trading restrictions, blackout periods and company policies.

Even when a sale is lawful and economically sensible, investors may interpret it as a lack of confidence. The market’s interpretation may have little to do with the shareholder’s actual reason for selling.

The shareholder might simply want to purchase another business. The headline, however, may read: “Founder Reduces Stake.”

Markets are not always famous for nuance.

5. Selling may create tax consequences

A sale can produce capital gains or other tax consequences depending on the shareholder’s cost basis, residence, holding structure and applicable laws.

Borrowing is not automatically tax-free, and the tax treatment of any transaction must be evaluated by qualified advisers. Nevertheless, a loan does not begin with the same immediate sale of shares that would ordinarily crystallize a gain or loss.

Tax outcomes are highly jurisdiction-specific. No shareholder should assume that a particular treatment applies without professional advice.

6. The shareholder may have an emotional connection

A founder’s shares may represent decades of work, risk, sacrifice and identity. A family’s position may be connected to its history.

This does not mean emotion should control financial planning. It does mean that the instruction to “just sell some stock” may ignore the real significance of the asset.


The Liquidity Paradox

A concentrated shareholder can simultaneously possess:

  • High net worth

  • Strong economic exposure

  • Significant voting power

  • Limited liquid reserves

  • Limited borrowing capacity under conventional underwriting

  • A large opportunity cost associated with selling

This produces what might be called the liquidity paradox: the shareholder is wealthy because of the position but financially constrained because so much wealth remains inside it.

Traditional banks may emphasize income, cash flow, real estate, guarantees and a broad personal balance sheet. A shareholder whose wealth is concentrated in listed securities may not fit neatly into conventional lending models—particularly when the requested financing is large, cross-border or intended for a time-sensitive opportunity.

Specialized securities-backed lenders may evaluate the situation differently. Their analysis begins with the collateral.

How Securities-Backed Lending May Work

How Securities-Backed Lending May Work

In a securities-backed lending transaction, a qualified shareholder pledges eligible publicly traded shares as collateral for a loan. The independent lender evaluates the shares, the borrower, the proposed use of proceeds, the repayment strategy and the transaction’s overall risk before deciding whether financing is available and on what terms.

One of the most important measurements is the loan-to-value ratio, commonly called LTV.

Calculating the Initial LTV

The LTV compares the outstanding loan balance with the current market value of the pledged collateral: LTV = (Outstanding Loan Balance/Current Market Value of Collateral) X 100

Suppose a shareholder pledges an eligible share position worth $100 million, and an independent lender approves a $55 million loan: Initial LTV = ($55,000,000/$100,000,000) x 100 Initial LTV = 55%

The shareholder has obtained $55 million in liquidity without initiating an outright sale of the pledged shares. However, the shareholder still retains the economic risk associated with changes in the collateral’s value, subject to the specific rights and terms established in the loan documents.

What Happens When the Share Price Declines?

The loan balance does not automatically decline when the share price falls. Consequently, a decline in collateral value causes the LTV to rise—even if the borrower receives no additional funds.

Assume the pledged shares decline by 25%.

The new collateral value can be calculated as follows: Revised Collateral Value = Initial Collateral Value x (1 - Percentage Decline) Revised Collateral Value = $100,000,000 x (1 - 0.25) Revised Collateral Value = $75,000,000

If the loan balance remains at $55 million, the revised LTV becomes: Revised LTV = ($55,000,000/$75,000,000) x 100 Revised LTV ≈ 73.33%

The borrower has not received another dollar, but the LTV has increased from 55% to approximately 73.33%.

Measurement

At Closing

After 25% Decline

Collateral value

$100 million

$75 million

Loan balance

$55 million

$55 million

LTV

55%

73.33%

This illustrates a central principle of securities-backed lending:

When collateral value falls and the loan balance remains unchanged, leverage rises.

Measuring the Remaining Equity Cushion

Another useful calculation is the shareholder’s remaining equity in the pledged position:

Collateral Equity = Collateral Value - Outstanding Loan Balance At closing: $100,000,000 - $55,000,000 = $45,000,000 After the 25% decline:

$75,000,000 - $55,000,000 = $20,000,000

Although the collateral declined by $25 million, the loan balance remained unchanged. The shareholder’s collateral equity therefore fell from $45 million to $20 million—a reduction of approximately 55.56%: Equity Decline = ($45,000,000 - $20,000,000/$45,000,000) x 100 Equity Decline ≈ 55.56%

This is the amplifying effect of leverage: a 25% decline in the collateral’s market value produces a much larger percentage decline in the shareholder’s remaining collateral equity.

Understanding Maintenance LTV

The initial LTV is only the starting point. A loan agreement may also establish a maintenance LTV—a level that the borrower must not exceed.

If the loan balance is L and the maintenance threshold is M, the collateral value at which that threshold is reached can be estimated as:


Threshold Collateral Value = L/M

For example, if the outstanding loan is $55 million and the maintenance LTV is hypothetically 70%: Threshold Collateral Value = $55,000,000/0.70 Threshold Collateral Value = $78,571,429

The corresponding decline from the original $100 million collateral value would be:

Permitted Decline = 1 - ($78,571,429/$100,000,000) Permitted Decline ≈ 21.43%

Under this purely hypothetical threshold, a decline of approximately 21.43% would cause the LTV to reach 70%. A 25% decline would push it above that level, subject to the agreement’s valuation methods, cure provisions and other terms.

Actual initial and maintenance LTVs are determined by the independent lender and may vary substantially according to the security, market, volatility, liquidity, transaction structure and applicable documentation.

Responding to a Collateral Shortfall

If the LTV exceeds an agreed maintenance threshold, the loan documents may allow or require the borrower to:

  • Pledge additional eligible collateral

  • Repay part of the outstanding principal

  • Cure the shortfall within a specified period

  • Accept the lender’s sale or other realization of collateral

  • Take another action permitted by the agreement

The amount of principal repayment required to restore a target LTV can be expressed as: Required Principal Repayment = Current Loan Balance - (Current Collateral Value x Target LTV)

Using the example above, restoring the loan to a hypothetical 70% LTV after the collateral falls to $75 million would require: Required Principal Repayment = $55,000,000 - ($75,000,000 x 0.70) Required Principal Repayment = $55,000,000 - $52,500,000 Required Principal Repayment = $2,500,000

Alternatively, if permitted, the borrower could potentially restore the target LTV by contributing additional eligible collateral. The required additional collateral value would be: Additional Collateral Required = (Current Loan Balance/Target LTV) - Current Collateral Value Additional Collateral Required = ($55,000,000/0.70) - $75,000,000 Additional Collateral Required ≈ $3,571,429

Whether additional collateral may be posted—and what securities qualify—is governed entirely by the loan agreement and lender requirements.

The More Important Borrowing Question

A securities-backed loan may convert part of a concentrated shareholding’s value into deployable capital without an immediate voluntary sale. It does not remove market risk, repayment obligations or the possibility of collateral enforcement.

The essential question is therefore not simply:

How much can I borrow?

It is:

How much can I prudently borrow while maintaining sufficient protection against a substantial decline in the pledged shares?

Maximum borrowing capacity and prudent borrowing capacity may be very different numbers. A carefully considered collateral buffer can give the shareholder more room to withstand volatility, satisfy ongoing obligations and avoid being forced to respond during unfavorable market conditions.


What Determines Whether Shares Are Financeable?

Not every public security is suitable collateral. A ticker symbol and a quoted price are only the beginning of the analysis.

Trading liquidity

Lenders commonly examine average daily trading volume and the size of the proposed collateral position relative to that volume.

A company may have a large market capitalization but limited trading activity. If the lender could not realize the collateral efficiently during a default, the apparent market value may overstate its practical value for lending purposes.

Market capitalization

Larger companies may offer deeper markets, more analyst coverage and broader institutional ownership. Smaller issuers may present greater price volatility and execution risk.

Market capitalization alone, however, is not enough. A large company with a tightly held share register can still have limited free float.

Volatility

The more rapidly a security’s price can change, the more cautiously a lender may approach its collateral value.

Higher volatility may result in:

  • A lower advance rate

  • A lower permitted LTV

  • A larger collateral requirement

  • Tighter monitoring

  • More conservative maintenance thresholds

  • Different pricing or other loan conditions

Exchange and jurisdiction

The lender will consider where the shares trade, how the market operates, the reliability of settlement systems, applicable custody arrangements and the enforceability of the collateral documents.

Altivolus Capital Partners focuses on introductions involving qualified shareholders and eligible securities in supported international markets. Availability is subject to lender criteria, applicable law and jurisdictional restrictions. Services are not offered for U.S., Russian, mainland Chinese or Indian securities markets.

Free float and ownership concentration

A large position may represent a meaningful percentage of the company’s freely tradable shares. That can make the collateral more difficult to liquidate without affecting the market.

Ironically, the shareholder’s importance to the company can make the position both more valuable strategically and more challenging financially.

Corporate events

Lenders may examine upcoming events such as:

  • Earnings announcements

  • Lock-up expirations

  • Mergers and acquisitions

  • Tender offers

  • Rights issues

  • Dividend changes

  • Regulatory decisions

  • Major litigation

  • Index additions or removals

  • Changes in control

These events can alter the price, liquidity or legal status of the collateral.

Legal and transferability considerations

Shares may be subject to restrictions arising from securities laws, shareholder agreements, lock-ups, pledges, liens, insider status or other contractual arrangements.

A position cannot function effectively as collateral if it cannot legally or operationally be transferred, pledged or realized in accordance with the proposed transaction.

What Could the Liquidity Be Used For?

Subject to lender restrictions, applicable laws and the final loan agreement, proceeds may support a wide range of strategic objectives.

Business expansion

A founder may use liquidity to capitalize another operating company, acquire equipment, enter a new market or fund a corporate acquisition.

Portfolio diversification

A shareholder may seek to reduce overall economic concentration by deploying borrowed capital into other assets.

This requires careful analysis. Borrowing against one investment to purchase another adds leverage and may create multiple sources of loss. Diversification financed with debt is not equivalent to diversification financed with unencumbered cash.

Real estate

Proceeds might contribute to the purchase, development or refinancing of commercial property, hospitality assets, land or high-value residential real estate.

Bridge financing

A securities-backed loan may provide capital while a borrower awaits another transaction, such as an asset sale, refinancing, dividend, business distribution or scheduled liquidity event.

The quality and timing of the exit strategy are critical. “Something will work out” is not an exit strategy.

Family-office and estate planning objectives

A family office may need liquidity for investments, distributions, commitments, philanthropy or intergenerational planning without immediately selling a core holding.

Legal, tax and estate-planning advisers should review the structure.

Major lifestyle acquisitions

Qualified borrowers may also consider financing for high-value personal acquisitions such as a superyacht, aircraft or international property.

The glamour of the asset does not change the mathematics of the loan. Interest, collateral volatility and repayment obligations remain decidedly unglamorous.


Why Borrowing Is Not the Same as Selling

Selling and borrowing solve the liquidity problem in fundamentally different ways.

Consideration

Selling Shares

Borrowing Against Eligible Shares

Immediate liquidity

Generated from sale proceeds

Generated from loan proceeds

Ownership exposure

Reduced

May continue, subject to the agreement

Future appreciation

Foregone on shares sold

Potential exposure may continue

Future depreciation

Avoided on shares sold

Collateral remains exposed

Debt obligation

None from the sale

Principal, interest and fees apply

Collateral-call risk

None

May be significant

Tax implications

Sale may trigger consequences

Depends on structure and jurisdiction

Market signaling

Sale may become visible

Depends on disclosure rules and circumstances

Exit requirement

Not applicable

Loan requires repayment or refinancing

Neither option is automatically superior. The appropriate choice depends on the shareholder’s goals, risk capacity, tax situation, time horizon and confidence in the underlying security.

The Risks That Deserve the Most Attention

Securities-backed lending can create liquidity, but it can also magnify vulnerability. The central risks should be understood before any agreement is signed.

Collateral-value risk

Share prices can fall rapidly. A position that appeared conservatively leveraged at closing may become highly leveraged after a severe decline.

Investor.gov specifically warns that when a portfolio is concentrated in one stock or sector, a single event can sharply reduce its value, potentially trigger a maintenance call and lead to liquidation during a market downturn. (Investor.gov: Securities-Backed Lines of Credit)

Forced-sale risk

If a borrower cannot satisfy a collateral shortfall, the lender may have contractual rights to sell or otherwise realize the pledged securities.

That outcome can be especially damaging because the sale may occur when:

  • The share price is already depressed

  • Trading liquidity is deteriorating

  • The shareholder least wants to sell

  • Tax consequences are unfavorable

  • The company is approaching an important event

The very sale the shareholder hoped to avoid may occur under worse conditions.

Interest-rate risk

Some facilities use floating interest rates based on a benchmark plus a lender spread. If the benchmark rises, the cost of borrowing may increase.

Borrowers should model the transaction under multiple interest-rate scenarios—not merely the initial quoted rate. At Altivolus Capital Partners, we align ourselves with lending resources that provide a fixed interest rate for the entirety of the loan.

Currency risk

If the collateral, loan and intended use of proceeds involve different currencies, exchange-rate movements can change the economics of the transaction.

For example, a shareholder may pledge euro-denominated shares, borrow in another currency and acquire an asset priced in a third. That creates more than a stock-price decision; it creates a multi-currency balance sheet.

Counterparty and documentation risk

The identity, reputation and financial capacity of the lender matter. So do the custody structure, collateral arrangements, permitted uses of the securities, events of default and enforcement rights.

Borrowers should understand:

  • Who legally holds the pledged shares

  • Whether title transfers or a security interest is created

  • Whether the lender may use, rehypothecate or otherwise deal with the shares

  • How dividends and other distributions are treated

  • Whether voting rights are retained

  • What happens during a corporate action

  • What constitutes a default

  • What notice and cure periods apply

  • Under what circumstances collateral may be sold

  • How the shares are returned after repayment

The commercial summary may be only a few pages. The clauses that determine what happens during a crisis are usually found deeper in the documents.

Opportunity risk

Borrowed capital must accomplish something useful enough to justify its cost and risk.

Using the proceeds to acquire a productive business may create a potential return and repayment source. Using them to support recurring expenses without a credible exit may gradually weaken the borrower’s position.

Liquidity is a tool. It is not the same thing as income.

The Buffer Principle

One of the most important concepts in securities-backed lending is the collateral buffer.

Assume a lender is willing to offer a particular maximum LTV. That does not mean borrowing the maximum is prudent.

A lower initial LTV can provide more room for:

  • Ordinary market volatility

  • Adverse company news

  • Currency movements

  • Interest accumulating to the balance

  • Changes in collateral eligibility

  • Temporary market dislocation

Consider a $100 million position:

Scenario

Loan Balance

Collateral Value After 40% Decline

Resulting LTV

Conservative borrowing

$10 million

$60 million

16.7%

Moderate borrowing

$20 million

$60 million

33.3%

Aggressive borrowing

$40 million

$60 million

66.7%

The security declined by the same amount in every scenario. The borrower’s resilience did not.

Maximum borrowing capacity and sensible borrowing capacity are two different numbers.


A Hypothetical Concentrated-Shareholder Case

Consider Elena, the fictional founder of a European logistics company listed on an eligible international exchange.

Her position is worth approximately $120 million. It represents most of her personal net worth. She believes strongly in the company’s long-term prospects and does not want to sell a meaningful portion of her stake.

At the same time, she has an opportunity to acquire a regional warehousing business for $18 million. The target is profitable, strategically complementary and available under a time-sensitive process.

Elena appears extraordinarily wealthy, but her available cash is insufficient for the acquisition. Selling company shares could reduce her ownership and potentially affect market perceptions.

A securities-backed lender evaluates:

  • The company’s market capitalization

  • Average daily trading volume

  • The size of Elena’s position

  • Free float

  • Historical volatility

  • Concentration and liquidation risk

  • Her legal ability to pledge the shares

  • The proposed acquisition

  • The source of interest payments

  • Her repayment and exit strategy

  • The relevant jurisdictions

Suppose the lender ultimately approves a $15 million facility—not the full $18 million requested. Elena contributes $3 million from other resources.

The structure may allow her to complete the acquisition without an immediate sale of the pledged shares. She nevertheless remains exposed to several risks:

  • Her public-company shares could decline

  • The acquired business could underperform

  • Interest costs could rise

  • Currency movements could affect returns

  • A collateral shortfall could require additional capital

  • The lender could exercise contractual remedies following a default

The transaction has not made the risk disappear. It has rearranged the risk to support a strategic objective.

That is the proper way to view share financing: not as financial magic, but as balance-sheet engineering.

Questions a Shareholder Should Ask Before Proceeding

A thoughtful evaluation should include at least the following questions:

  1. What is the exact identity of the lender?

  2. Which shares are eligible, and how will they be valued?

  3. What initial and maintenance LTV levels apply?

  4. How frequently will the collateral be marked to market?

  5. What happens if the share price falls by 20%, 40% or 60%?

  6. Can additional collateral be posted?

  7. What notice and cure periods apply after a shortfall?

  8. Under what circumstances may the lender sell the collateral?

  9. Who holds legal title or a security interest in the shares?

  10. Can the shares be transferred, lent, hedged or rehypothecated?

  11. What happens to dividends and voting rights?

  12. How are stock splits, rights issues, tender offers and other corporate actions handled?

  13. Is the interest rate fixed or floating?

  14. What fees apply in addition to interest?

  15. Are there prepayment costs or minimum-interest provisions?

  16. Does the loan contain restrictions on the use of proceeds?

  17. What reporting obligations apply?

  18. What is the primary repayment source?

  19. What is the backup repayment source?

  20. Have qualified legal, tax and financial advisers reviewed the complete arrangement?

A borrower should also verify every party independently. High-value lending attracts legitimate institutions—and occasionally sophisticated impersonators. Fraud prevention and counterparty verification are essential.

How Altivolus Capital Partners Helps

Altivolus Capital Partners markets its share-financing introduction services through Altivolus Stock Loans.

We help qualified international shareholders explore whether their eligible publicly traded shares may support a securities-backed lending opportunity. Our role is to facilitate strategic introductions between prospective borrowers and independent international lenders.

Altivolus Capital Partners:

  • Does not provide the loan

  • Does not make underwriting decisions

  • Does not determine or negotiate loan terms

  • Does not provide investment, legal or tax advice

  • Does not act as a broker-dealer or registered investment adviser

  • Does not take possession of client funds or securities

All financing decisions, collateral requirements, documentation and loan terms are determined directly by the independent lender. Altivolus Capital Partners may receive a referral fee from a lender if an introduced borrower completes a transaction.

Our objective is straightforward: help appropriate shareholders reach the right conversations, understand the introduction process and approach securities-backed borrowing with greater preparation.


From Paper Wealth to Strategic Liquidity

A concentrated shareholding can be both a triumph and a constraint.

It may represent a company built from nothing, a visionary investment held through years of uncertainty or a family asset preserved across generations. Its value may be enormous. Its liquidity may be surprisingly limited.

The traditional answer is to sell.

Sometimes that is the correct answer.

But for qualified shareholders with eligible international securities, an appropriately structured stock loan may offer another path: accessing capital while avoiding an immediate voluntary sale of the pledged position.

The decision requires discipline. Borrowers must examine collateral volatility, LTV, interest costs, lender rights, currency exposure, repayment capacity and downside scenarios. A stock loan should never be evaluated solely by the amount of cash available on closing day.

The real measure is whether the financing remains manageable when markets become less cooperative.

Because wealth on paper can be impressive.

Strategic liquidity is what makes wealth actionable.


Important Information

This article is provided for general educational and informational purposes only. It does not constitute financial, investment, legal, tax or lending advice, an offer to lend, or a solicitation to enter into any transaction.

Securities-backed lending involves substantial risks, including market loss, interest expense, collateral calls, forced liquidation, loss of voting or dividend-related rights, counterparty risk, currency risk and possible tax consequences. Retaining exposure to pledged shares means retaining the risk that those shares may decline in value.

Altivolus Capital Partners acts solely as an introducer between prospective borrowers and independent lenders. It is not a lender, broker-dealer or registered investment adviser. Altivolus Capital Partners does not structure or negotiate loans, provide underwriting, determine terms, hold client assets or guarantee financing. All applications, terms, approvals and agreements are handled directly by the lender.

Availability depends on the borrower, security, exchange, lender requirements, applicable law and jurisdiction. Services are not offered for securities listed in the United States, Russia, mainland China or India. Prospective borrowers should obtain independent legal, tax, investment and financial advice and conduct appropriate due diligence before entering any transaction.

Altivolus Capital Partners | Altivolus Stock Loanswww.AltivolusStockLoans.com

 
 
 

Comments


bottom of page